The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation
- PMID: 1321284
- PMCID: PMC241358
- DOI: 10.1128/JVI.66.8.5018-5029.1992
The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation
Abstract
The v-rel oncogene product from the avian reticuloendotheliosis virus strain T corresponds to a member of the Rel-related family of enhancer-binding proteins that includes both the mammalian 50- and 65-kDa subunits of the NF-kappa B transcription factor complex. However, in contrast to NF-kappa B, v-Rel has been shown to function as a dominant-negative repressor of kappa B-dependent transcription in many mature cell types. We now demonstrate that a highly conserved motif within the Rel homology domain of v-Rel containing a consensus protein kinase A phosphorylation site is required for DNA binding, transcriptional repression, and cellular transformation mediated by this oncoprotein. However, replacement of the serine phosphate acceptor within the protein kinase A site with an alanine did not alter any of these functions of v-Rel, suggesting that phosphorylation at this site is not central to the regulation of this oncogene product. Rather, the inactive mutations appear to identify a functional domain within v-Rel required for these various biological activities. It is notable that these same mutations do not impair the ability of v-Rel to heterodimerize with the 50-kDa subunit of NF-kappa B, suggesting that v-Rel-mediated transcriptional repression likely involves direct nuclear blockade of the kappa B enhancer rather than indirect alterations in the composition of preformed cytoplasmic NF-kappa B complexes. Paradoxically, when introduced into undifferentiated F9 cells, v-Rel functions as a kappa B-specific transcriptional activator rather than as a dominant-negative repressor. These stimulatory effects of v-Rel require both the conserved protein kinase A phosphorylation site and additional unique C-terminal sequences not needed for v-Rel-mediated repression in mature cells. Retinoic acid-induced differentiation of these F9 cells restores the repressor function of v-Rel. These opposing biological actions of v-Rel occurring in cells at distinct stages of differentiation may have important implications for the mechanism of v-Rel-mediated transformation occurring in avian splenocytes.
Similar articles
-
I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.Mol Biol Cell. 1992 Dec;3(12):1339-52. doi: 10.1091/mbc.3.12.1339. Mol Biol Cell. 1992. PMID: 1493333 Free PMC article.
-
Interaction of the v-rel protein with an NF-kappa B DNA binding site.Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1783-7. doi: 10.1073/pnas.88.5.1783. Proc Natl Acad Sci U S A. 1991. PMID: 1848011 Free PMC article.
-
The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.Oncogene. 1988 Oct;3(4):349-55. Oncogene. 1988. PMID: 2856247
-
The Rel family: models for transcriptional regulation and oncogenic transformation.Biochim Biophys Acta. 1992 Sep 14;1114(1):1-17. doi: 10.1016/0304-419x(92)90002-g. Biochim Biophys Acta. 1992. PMID: 1327144 Review. No abstract available.
-
Molecular mechanisms of transformation by the v-rel oncogene.Crit Rev Oncog. 1991;2(4):293-309. Crit Rev Oncog. 1991. PMID: 1958712 Review.
Cited by
-
OHMM: a Hidden Markov Model accurately predicting the occupancy of a transcription factor with a self-overlapping binding motif.BMC Bioinformatics. 2009 Jul 7;10:208. doi: 10.1186/1471-2105-10-208. BMC Bioinformatics. 2009. PMID: 19583839 Free PMC article.
-
Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif.Mol Cell Biol. 1993 Mar;13(3):1572-82. doi: 10.1128/mcb.13.3.1572-1582.1993. Mol Cell Biol. 1993. PMID: 8441398 Free PMC article.
-
Evolution of the oncogenic potential of v-rel: rel-induced expression of immunoregulatory receptors correlates with tumor development and in vitro transformation.J Virol. 1994 Apr;68(4):2039-50. doi: 10.1128/JVI.68.4.2039-2050.1994. J Virol. 1994. PMID: 8138989 Free PMC article.
-
Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.J Virol. 1995 Jun;69(6):3369-80. doi: 10.1128/JVI.69.6.3369-3380.1995. J Virol. 1995. PMID: 7745683 Free PMC article.
-
Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids.J Virol. 1994 Apr;68(4):2073-83. doi: 10.1128/JVI.68.4.2073-2083.1994. J Virol. 1994. PMID: 8138992 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous